Baroness Professor Susan Greenfield, CBE
CEO and Founder
Baroness Greenfield, Founder and CEO of Neuro-Bio Ltd is a neuroscientist and has published over 200 papers in peer-reviewed journals over the course of her 40-year career, based mainly at Oxford University. She holds 32 honorary degrees from UK and foreign universities, has received numerous honours including the Legion d’Honneur from the French Government, an Honorary Fellowship from the Royal College of Physicians, The American Academy of Achievement Golden Plate Award, and The Australian Medical Research Society Medal. She is also a Fellow of the Royal Society of Edinburgh.
Chairman of the Board
Craig is a British Scientist, Engineer & Business Leader based in Arizona, USA. He has advised and built accelerated Clinical Trial Platforms (Pfizer & FDA). Craig also has a wealth of Exec and board experience in UK and US start-ups and US Public Companies. Throughout this, he has achieved substantial exits through M&A and IPO’s (NASDAQ). In addition to this, Craig is a Board Member of XPRIZE Foundation.
Dr Michal Zurawski
Chairman of the Commercial Advisory Board
Dave is the former chairman and CEO of Office Depot and former president of Sherwin-Williams Paint Stores. In addition to his role as Chairman Emeritus of SSA & Company, he is a Senior Advisor at Peter J. Solomon Company. He formerly served on the boards of Office Depot, Ryder Transportation, Dicks Sporting Good and others. Dave was appointed on the board by Kairos Ventures as an Investor Director for Neuro-Bio.
Todd is an accomplished operating executive and entrepreneur, having served as Citigroup CFO for 5
years and as CEO of Citigroup’s $10 Billion Global Wealth Management division for 2.5 years. Todd is a
leading practitioner on M&A and business strategy, having led the acquisition and strategy efforts for
Citigroup and GE Capital, as well as serving as advisor to Fortune 500 firms while at Bain & Co., Booz
Allen Hamilton, and Barents Group.
At Kairos, Todd oversees all operational and financial aspects of the firm and serves on the Kairos
Investment Committee. Kairos has partnered closely with 16 prominent universities to select and
commercialize their most ground-breaking patented innovations in life sciences and physical sciences.
Todd received his MBA, with Distinction, from the Wharton School of Business and his BA in Economics
from Davidson College.
James is the founder and Chief Executive of Dragon Argent (formerly Clink Ltd), which provides integrated legal, financial, HR and other professional services to hundreds of tech startups and SME’s, often internationally. James advises a large number of these high growth, entrepreneurial businesses at board level. Having set up his first successful business at 14 (buying and selling old red telephone kiosks), he is a widely experienced entrepreneur and consummate professional, whose passion, integrity and assistance have always been critical to any organisation with which he has been involved.
Watch Professor Herrling contribute to the Press Conference held on the 5th of April 2022 at the Royal College of Physicians
T: +44 (0)1235 420 085
© All Rights Reserved NeuroBio